Navigation Links
BioSyntech Reports Positive Results from Pivotal Trial for BST-CarGel(R) Cartilage Repair Device
Date:6/17/2009

LAVAL, QC, June 17 /PRNewswire-FirstCall/ - BioSyntech, Inc. (TSX: BSY), a biotechnology company developing biotherapeutic thermogels for regenerative medicine, today announced statistically significant results from an analysis of patients who completed their 12 month follow-up in the BST-CarGel(R) randomized clinical trial. Specifically, statistically significant evidence of improved repair tissue quality due to BST-CarGel treatment was found during analyses of tissues biopsied from the knees of 22 patients. The ongoing multicenter pivotal trial is evaluating the ability of BST-CarGel to repair cartilage lesions in the knee when applied to a microfractured lesion compared to microfracture alone (control) in 80 patients. Final results on all 80 patients are expected in the first half of 2010.

"We are excited by these positive results, which will be highly supportive in our ongoing discussions with potential orthopedic partners. Although we have not yet completed all facets of this Interim Analysis, we felt obligated to disclose these first histology results as biopsy data is considered the gold standard for assessment of cartilage repair," said Mr. Michel Lagueux, Chairman of the Board.

Using histological methods (i.e. analyses by microscope) to process and analyze the biopsied tissues from 13 BST-CarGel patients and 9 microfracture patients, and using third parties to perform the statistical analysis, statistically significant improvements were identified for critical tissue characteristics following BST-CarGel treatment compared to microfracture alone. In particular, after applying the International Cartilage Repair Society's (ICRS) histological scoring systems I and II to the biopsies in a blinded manner, several parameters were found to be statistically significant between treatment groups at p(less than)0.05. First, the Overall ICRS II score was significantly better for the BST-CarGel group than for the microfracture group (p=0.045), with
'/>"/>

SOURCE BioSyntech, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. BioSyntech Achieves Enrolment Goal for Pivotal Trial of BST-CarGel(R), its Cartilage Repair Device
2. BioSyntech to conclude enrolment for pivotal BST-CarGel(R) trial in February 2009
3. Neurim Pharmaceuticals Reports Long Term Efficacy and Safety for Circadin(R) for Insomnia in Elderly Patients
4. Repligen Reports Fourth Quarter and Fiscal Year 2009 Financial Results
5. Human Genome Sciences Reports Positive Long-Term Data for BENLYSTA(TM) (Formerly LymphoStat-B(R)) in Patients With Active Systemic Lupus Erythematosus
6. Keryx Biopharmaceuticals Reports Positive Phase 2 Study Results of Zerenex (Ferric Citrate) for the Treatment of Hyperphosphatemia in End-Stage Renal Disease Patients
7. PeriCor Therapeutics Reports Positive Preclinical Results of GP531 at the European Heart Failure Congress in Nice
8. Mersana Reports Preliminary Phase 1 Results of XMT-1001 in Patients with Advanced Solid Tumors
9. Valeant Pharmaceuticals Reports Encouraging Final Results With Taribavirin Phase IIb Study
10. Biostar Pharmaceuticals, Inc. Reports Continued Revenues and Earnings Growth in First Quarter of 2009
11. Neptune Technologies Reports Fiscal 2009 Results - Record revenue and profitability growth in nutraceutical business

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)..., LIBREVILLE, Gabon, December 2 /PRNewswire/ ...: Everyone,s Problem and Heritage" , Coin..., 2-3 June 2010 the,Gabonese Republic is hosting a...n the issue of safeguarding biological resources i...nment and state leaders, ministers,scientific exp...
(Date:12/2/2009)... , CAMBRIDGE, Mass., Dec. 2 T...eaders in technology development and product integ...nnounced the December 11th deadline for technology...n its 14th year, TechConnect World, in association...STI), and the Clean Technology and Sustainable Ind...
(Date:12/2/2009)... , SINGAPORE, Dec. 2 S*BIO Pt...vel oral JAK2 inhibitor, SB1518, at The American S...ition in New Orleans. ,, Data will be presented...alation trial of SB1518 detailing its safety, tole...D) profile in dose levels ranging from 100 to 600 ...
(Date:12/2/2009)..., NANJING, China, Dec. 2 /PRNewswire-Asia/ ..."Company") (NYSE: SCR ), a leading pharmaceutica...turing, and marketing of branded,generic and propr...hat 105 of,its drugs have been included in China,s...was issued by China,s Ministry of Human Resources ...
Breaking Biology Technology:Libreville International Conference 2-3 June 2010 2Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 2Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 2Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 3
...LLESLEY HILLS, Mass., March 5 Joseph F. Finn, Jr.... ActivBiotics, confirmed,today that the sale of Ac...,through a sealed bid at 12:00 PM on March 14, 200...s parties about different aspects of the,technolog...es, in addition,to comprehensive due diligence, I ...
...ropean phase II study of 20 patients reported in A...utics, Inc.,(CTI) (Nasdaq: CTIC ; MTA) today anno...s, of results of a limited phase II study of CHOP ...istine, and prednisone) followed by,administration...atients (60,years of age or older) with previously...
...EMONT, Calif., March 4 Vermillion, Inc.,(Nasdaq: ...ighlighted recent,accomplishments across its diagn...business milestones it plans to achieve over the c... results for the fourth quarter and year,ended Dec...icant clinical and commercial,advancements in our ...
Other Biology Technology:CHOP-Zevalin(R) Investigational Regimen Produces 95% Complete Remission and 75% Estimated Two Year Progression-Free Survival in Elderly Patients with Diffuse Large B-cell Lymphoma 2CHOP-Zevalin(R) Investigational Regimen Produces 95% Complete Remission and 75% Estimated Two Year Progression-Free Survival in Elderly Patients with Diffuse Large B-cell Lymphoma 3CHOP-Zevalin(R) Investigational Regimen Produces 95% Complete Remission and 75% Estimated Two Year Progression-Free Survival in Elderly Patients with Diffuse Large B-cell Lymphoma 4Vermillion Summarizes Recent Accomplishments and 2007 Financial Results; Outlines 2008 Business Milestones 2Vermillion Summarizes Recent Accomplishments and 2007 Financial Results; Outlines 2008 Business Milestones 3Vermillion Summarizes Recent Accomplishments and 2007 Financial Results; Outlines 2008 Business Milestones 4Vermillion Summarizes Recent Accomplishments and 2007 Financial Results; Outlines 2008 Business Milestones 5Vermillion Summarizes Recent Accomplishments and 2007 Financial Results; Outlines 2008 Business Milestones 6Vermillion Summarizes Recent Accomplishments and 2007 Financial Results; Outlines 2008 Business Milestones 7Vermillion Summarizes Recent Accomplishments and 2007 Financial Results; Outlines 2008 Business Milestones 8Vermillion Summarizes Recent Accomplishments and 2007 Financial Results; Outlines 2008 Business Milestones 9
(Date:12/1/2009)...ology has been awarded a U.S. Air Force Center of ...vesting and adaptive materials, and to develop too... modern warfighter. , The $10.5 million Center,...anostructures and Improved Cognition (BIONIC) cent...andhage, professors in Georgia Tech,s School of Ma...
(Date:12/1/2009)...rsity-led international research team has develope...t generation of solar cells. , Scientists at Mon...rom the universities of Wollongong and Ulm in Germ...ls with a three-fold increase in energy conversion...em dye-sensitised solar cells. , Lead researche...
(Date:11/30/2009)... needed to monitor the commitments that will be ma...eir deforestation rates, according to research at ...gencies and research groups have failed to make fu... Earth,s surface collected each week to monitor tr... Alan Grainger in the Proceedings of the National...
Breaking Biology News(10 mins):Air Force Center of Excellence awarded in nanostructures and improved cognition 2Air Force Center of Excellence awarded in nanostructures and improved cognition 3Air Force Center of Excellence awarded in nanostructures and improved cognition 4Innovation puts next-generation solar cells on the horizon 2World forest observatory needed to monitor vital role of forests in climate deal 2Study of DuraPrep versus chlorhexidine 59252 1Study of DuraPrep versus chlorhexidine 59252 2New approach for growing bone comes from Duke preclinical research 14418 1New approach for growing bone comes from Duke preclinical research 14418 2Loyal alligators display the mating habits of birds 10313 1Loyal alligators display the mating habits of birds 10313 2
... at Washington University in St. Louis, has discov...n-off –in this case, the turning off of thousands ...udying the phenomenon of nucleolar dominance, in w...id is silenced, Craig Pikaard, Ph.D., Washington U...ces and colleagues have identified the protein HDA...
...llogg Eye Center have gained new insight into the ...mits itself to a specific role. They have observed... has been designated to play a particular role, bu...covery provides a new vantage point for understand...raises the possibility of re-directing the product...
...sub-Saharan Africa, according to the World Health ...inst the virus have achieved limited success. But ...tted infection found widely in that region of Afri...could reduce transmission of HIV as much as 10-fol...s from the University of North Carolina at Chapel ...
Other Biology News:Researchers find protein that silences genes 2Researchers find protein that silences genes 3Researchers find protein that silences genes 4Study provides first look at the 'birth' of a retina cell 2Study provides first look at the 'birth' of a retina cell 3Vaccine shown effective against chancroid 2Vaccine shown effective against chancroid 3
...cifically for pharmaceutical powder packaging, pur...ision-joined to create ultra-smooth surfaces that ...us corners simplify cleaning. Unique double-wall p...external bracing. A supplemental CLeanZone Recircu...
...ive reagent for the detection of inorganic phospha... E. coli phosphate-binding protein labeled with th...in its environment.How it worksBinding of inorgani... (Kd ~ 0.1 M), resulting in a large increase in fl...
Distillation Hood from Terra Universal, Inc.
...logical safety labs (BSL) and pharmaceutical appli...3) and easy sterilization. Panels are precision-jo... to wipe down and disinfect. One-inch radius corne...ign creates strong, rigid surface without external...
Biology Products: